The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression

por Rohrbacher, Lisa, Brauchle, Bettina, Ogrinc Wagner, Ana, von Bergwelt-Baildon, Michael, Bücklein, Veit L., Subklewe, Marion
Publicado en Front Immunol (2021)

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells

por Karschnia, Philipp, Strübing, Felix, Teske, Nico, Blumenberg, Viktoria, Bücklein, Veit L., Schmidt, Christian, Schöberl, Florian, Dimitriadis, Konstantinos, Forbrig, Robert, Stemmler, Hans-Joachim, Tonn, Joerg-Christian, von Bergwelt-Baildon, Michael, Subklewe, Marion, von Baumgarten, Louisa
Publicado en Hemasphere (2021)

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

por Lichtenegger, Felix S, Schnorfeil, Frauke M, Rothe, Maurine, Deiser, Katrin, Altmann, Torben, Bücklein, Veit L, Köhnke, Thomas, Augsberger, Christian, Konstandin, Nikola P, Spiekermann, Karsten, Moosmann, Andreas, Boehm, Stephan, Boxberg, Melanie, Heemskerk, Mirjam HM, Goerlich, Dennis, Wittmann, Georg, Wagner, Beate, Hiddemann, Wolfgang, Schendel, Dolores J, Kvalheim, Gunnar, Bigalke, Iris, Subklewe, Marion
Publicado en Clin Transl Immunology (2020)